Type
. Study with nine thalidomide derivatives in the lepra reaction. International journal of dermatology. 1978;17(1):82-4.
Type
. An attempt at passive transfer of immunity to leprosy patients by transfusion of allogeneic lymphocytes, inactivated with mitomycin C. Vox sanguinis. 1978;34(2):104-10.
Type
. Evidence for prevention of borderline leprosy reactions by dapsone. Lancet (London, England). 1976;2(7996):1171-2.
Type
. Observations of Langerhans' cells in leprosy using monoclonal antibody OKT6. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1984;52(4):524-6.
Type
. Effect of treatment on the cellular composition of cutaneous lesions in leprosy patients. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1984;52(4):496-500.
Type
. The effect of intervals between surveys on the estimation of incidence rates of leprosy. Leprosy review [Internet]. 1984;55(4):353-9. Available from: http://leprev.ilsl.br/pdfs/1984/v55n4/pdf/v55n4a06.pdf
Type
. Inhibition of interleukin-2 production by adherent cell factors from lepromatous leprosy patients. Clinical and experimental immunology. 1984;58(3):531-8.
Type
. Effect of leprosy sera and foetal calf serum (FCS) on the T cell number of peripheral blood of leprosy patients. Indian journal of leprosy. 1984;56(4):784-91.
Type
. A retrospective study of leprosy in an industrial hospital. The Journal of communicable diseases. 1984;16(3):169-75.
Type
. The cellular content of dermal leprous granulomas: an immuno-histological approach. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1984;52(3):318-26.